U.S. stocks rally on Fed minutes, earnings news

Once again, it was the Federal Reserve to the rescue for the stock market. Major U.S. indexes rose broadly Wednesday, helped by a report out of the nation's central bank that showed Fed policymakers want to be absolutely certain the U.S. economy had recovered before starting to raise interest rates.

The week ahead in business

Major economic reports will be issued Tuesday and Wednesday. This is also a big week for quarterly financial reports from companies such as Google, Citigroup, Bank of America, Kansas City Southern and Honeywell.

BofA paying $772M over selling credit card extras

Bank of America Corp. is paying $772 million in fines and refunds to settle regulators' accusations that it misled customers who bought extra credit-card products and illegally charged others for credit monitoring and reporting services they didn't receive.

Create a financial spring-cleaning list

A few things to include on your To-Do’s: Review your spending / savings spending plan. Take a look at your credit report and check for accuracy. Make sure your estate plan is up to date or get started on creating one.

U.S. stocks rise for the first time in four days

The stock market on Tuesday broke a three-day losing streak, pushing the Standard & Poor's 500 index back into positive territory for the year. The rebound was driven partly by bargain-hunting as investors picked up stocks that hold fallen the most in the slump over the previous three days.

Only two midsize SUVs get top rating in crash tests

Only two of nine midsize SUVs got the highest rating in crash tests done by an insurance industry group. The Chevrolet Equinox and GMC Terrain, both made by General Motors, received the highest "good" rating from the Insurance Institute for Highway Safety. The Toyota Highlander got the second-best "acceptable" rating in tests of 2014 models.

US jury hits Takeda, Eli Lilly with $9B penalty

A U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly and Co., to pay $9 billion in punitive damages over a diabetes medicine linked to cancer. The drug companies said Tuesday they will "vigorously challenge" the decision.